Science news articles about 'drug sensitivity'

... by Jerry Pelletier and colleagues, at McGill University, Montreal, have identified a drug that can enhance the sensitivity of mouse cancer cells to standard anticancer chemotherapeutic agents. In the ...

... process known as translation. Researchers have now identified a drug that inhibits translation and can enhance the sensitivity of mouse cancer cells to standard anticancer chemotherapeutic agents.

... to the model) has been infected with virus that remains susceptible to the primary drug. With drug-sensitive virus in the majority as people recover from infection and develop immunity, only a ...

... line regimens2. This underscores the need for effective drugs with the potential to shorten and improve MDR-TB ... TMC207 potently inhibits both drug-sensitive and drug-resistant M. tuberculosis isolates ...

... untreated hosts, allowing them to evolve ways to become more infectious and out-compete the drug-sensitive strains. The study also reveals that the contribution of transmission to the spread of drug ...

... therefore extend lifespan through its effects on S6K1. Together these studies provide evidence that this is a drug-sensitive pathway controlling mammalian ageing and suggest new approaches for the ...

... found that African Americans with a common form of lung cancer have a lower frequency of drug-sensitizing genetic mutations, which may impact response to new cancer-fighting drugs. Published online ...

... resistance exceeds three percent, we believe it is urgent to strengthen capacity to perform drug sensitivity testing, or to reevaluate these standard treatment regimens, given the unacceptably high ...

... lung cancer to EGFR gene blocking drugs. For example, a large number of Asian patients ... findings of this study were surprising since it was not expected that drug-sensitizing EGFR mutations would be so ...

... may be resistant to chemotherapy. Therefore, restoring cell death, or apoptosis, signaling may restore drug sensitivity. Christian Widmann, Ph.D., of Lausanne University in Switzerland, and colleagues ...